Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial (vol 21, pg 1099, 2022)

被引：0
|
作者：
Soileau, M. J.
Aldread, J.
Budur, K.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E5 / E5
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial (vol 223, pg 533, 2023)
    Loo, Colleen
    Glozier, Nick
    Barton, David
    Baune, Bernhard T.
    Mills, Natalie T.
    Fitzgerald, Paul
    Glue, Paul
    Sarma, Shanthi
    Galvez-Ortiz, Veronica
    Hadzi-Pavlovic, Dusan
    Alonzo, Angelo
    Dong, Vanessa
    Martin, Donel
    Nikolin, Stevan
    Mitchell, Philip B.
    Berk, Michael
    Carter, Gregory
    Hackett, Maree
    Leyden, John
    Hood, Sean
    Somogyi, Andrew A.
    Lapidus, Kyle
    Stratton, Elizabeth
    Gainsford, Kirsten
    Garg, Deepak
    Thornton, Nicollette L. R.
    Fourrier, Celia
    Richardson, Karyn
    Rozakis, Demi
    Scaria, Anish
    Mihalopoulos, Cathrine
    Chatterton, Mary Lou
    McDonald, William M.
    Boyce, Philip
    Holtzheimer, Paul E.
    Kozel, F. Andrew
    Riva-Posse, Patricio
    Rodgers, Anthony
    BRITISH JOURNAL OF PSYCHIATRY, 2024, 225 (02) : 349 - 349
  • [32] Evaluation of efficacy of opicapone in Parkinson's disease patients with motor fluctuations: phase III, randomized, double-blind, placebo and active-controlled study (BIPARK I)
    Ferreira, J.
    Lees, A.
    Santos, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 144 - 144
  • [33] Efficacy and Safety of Apomorphine Sublingual Film For the Treatment of "OFF" Episodes in Patients With Parkinson's Disease: A Phase 3, Double-Blind, Placebo-Controlled Trial
    Factor, S. A.
    Isaacson, S.
    Hauser, R. A.
    Pahwa, R.
    Sciarappa, K.
    Bhargava, P.
    Vakili, G.
    Blum, D.
    Navia, B.
    Olanow, C. W.
    MOVEMENT DISORDERS, 2019, 34 : S13 - S13
  • [34] Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
    Hauser, Robert A.
    Cantillon, Marc
    Pourcher, Emmanuelle
    Micheli, Federico
    Mok, Vincent
    Onofrj, Marco
    Huyck, Susan
    Wolski, Kenneth
    LANCET NEUROLOGY, 2011, 10 (03) : 221 - 229
  • [35] Efficacy, safety, and tolerability of lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
    Sharma, Namrata
    Basu, Sayan
    Shetty, Rohit
    Kumar, Pramod
    Mondal, Anindita
    Babu, P. Seshu
    Srivastava, Richa
    Pande, Ranjana A.
    Karat, Shubashree
    Desai, Hemaxi P.
    Manjula, S.
    Kumar, M. Krishna
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2025, 73 (01) : 88 - 94
  • [36] Efficacy and Safety of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients with Parkinson's Disease: A Phase 3, Double-blind, Placebo-controlled Trial
    Factor, Stewart A.
    Isaacson, Stuart
    Hauser, Robert A.
    Pahwa, Rajesh
    Sciarappa, Ken
    Bhargava, Parul
    Vakili, Gazal
    Blum, David
    Navia, Bradford
    Olanow, C. Warren
    NEUROTHERAPEUTICS, 2019, 16 (03) : 918 - 919
  • [37] Efficacy and Safety of Apomorphine Sublingual Film for The Treatment of "OFF" Episodes in Patients With Parkinson's Disease: Phase 3, Double-Blind, Placebo-Controlled Trial
    Factor, Stewart
    Isaacson, Stuart
    Hauser, Robert
    Pahwa, Rajesh
    Sciarappa, Kenneth
    Bhargava, Parul
    Vakili, Gazal
    Blum, David
    Navia, Bradford
    Olanow, C. Warren
    NEUROLOGY, 2019, 92 (15)
  • [38] Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind randomised, placebo-controlled trial
    Ovchinsky, Nadia
    Aumar, Madeleine
    Baker, Alastair
    Baumann, Ulrich
    Butler, Philip
    Cananzi, Mara
    Czubkowski, Piotr
    Durmaz, Oezlem
    Fischer, Ryan
    Indolfi, Giuseppe
    Karnsakul, Wikrom W.
    Lacaille, Florence
    Lee, Way S.
    Maggiore, Giuseppe
    Rosenthal, Philip
    Ruiz, Mathias
    Sokal, Etienne
    Sturm, Ekkehard
    Woerd, Wendy van der
    Verkade, Henkjan J.
    Wehrman, Andrew
    Clemson, Christine
    Yu, Qifeng
    Ni, Quanhong
    Ruvido, Jessica
    Manganaro, Susan
    Mattsson, Jan P.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (07): : 632 - 645
  • [39] Opicapone's efficacy in Parkinson's disease patients with motor fluctuations: a phase III, randomized, double-blind, placebo and active-controlled study - bipark I study
    Ferreira, J.
    Lees, A.
    Rocha, I.
    Santos, A.
    Lopes, N.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E284 - E285
  • [40] A double-blind placebo-controlled study of the efficacy of a single dose of subcutaneous apomorphine in advanced Parkinson's disease
    Koller, W
    NEUROLOGY, 2004, 62 (07) : A329 - A329
12345